Met Life Investment Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

A detailed history of Met Life Investment Management, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 34,090 shares of ZNTL stock, worth $64,430. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,090
Previous 34,090 -0.0%
Holding current value
$64,430
Previous $139,000 10.07%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$4.09 - $16.13 $13,856 - $54,648
3,388 Added 11.04%
34,090 $139,000
Q1 2024

May 14, 2024
BUY
$10.83 - $16.49 $332,502 - $506,275
30,702 New
30,702 $483,000
Q3 2023

May 09, 2024
BUY
$19.63 - $28.29 $113,186 - $163,120
5,766 Added 23.12%
30,702 $615,000
Q3 2023

Apr 29, 2024
BUY
$19.63 - $28.29 $101,251 - $145,919
5,158 Added 20.19%
30,702 $615,000
Q3 2023

Nov 14, 2023
BUY
$19.63 - $28.29 $101,251 - $145,919
5,158 Added 20.19%
30,702 $615,000
Q2 2023

Apr 29, 2024
BUY
$17.41 - $30.05 $444,721 - $767,597
25,544 New
25,544 $720,000
Q2 2023

Aug 10, 2023
BUY
$17.41 - $30.05 $10,585 - $18,270
608 Added 2.44%
25,544 $720,000
Q1 2023

May 09, 2024
BUY
$16.14 - $24.94 $402,467 - $621,903
24,936 New
24,936 $429 Million
Q3 2022

May 10, 2024
BUY
$20.23 - $31.73 $106,632 - $167,248
5,271 Added 26.8%
24,936 $540,000
Q3 2022

Mar 22, 2023
BUY
$20.23 - $31.73 $106,632 - $167,248
5,271 Added 26.8%
24,936 $540,000
Q3 2022

Nov 14, 2022
BUY
$20.23 - $31.73 $106,632 - $167,248
5,271 Added 26.8%
24,936 $540,000
Q2 2022

Jun 20, 2023
SELL
$17.91 - $52.25 $94,403 - $275,409
-5,271 Reduced 21.14%
19,665 $552,000
Q1 2022

May 10, 2024
BUY
$41.58 - $80.89 $817,670 - $1.59 Million
19,665 New
19,665 $907,000
Q1 2022

Jun 20, 2023
SELL
$41.58 - $80.89 $219,168 - $426,371
-5,271 Reduced 21.14%
19,665 $907,000
Q1 2022

Mar 22, 2023
BUY
$41.58 - $80.89 $296,839 - $577,473
7,139 Added 56.99%
19,665 $907,000
Q1 2022

May 12, 2022
BUY
$41.58 - $80.89 $296,839 - $577,473
7,139 Added 56.99%
19,665 $907,000
Q4 2021

Jun 21, 2023
SELL
$66.92 - $84.79 $830,477 - $1.05 Million
-12,410 Reduced 49.77%
12,526 $1.05 Million
Q3 2021

May 17, 2024
BUY
$46.83 - $73.5 $31,750 - $49,833
678 Added 5.72%
12,526 $834,000
Q3 2021

Jun 21, 2023
SELL
$46.83 - $73.5 $581,160 - $912,135
-12,410 Reduced 49.77%
12,526 $834,000
Q3 2021

Mar 22, 2023
BUY
$46.83 - $73.5 $31,750 - $49,833
678 Added 5.72%
12,526 $834,000
Q3 2021

Nov 15, 2021
BUY
$46.83 - $73.5 $31,750 - $49,833
678 Added 5.72%
12,526 $835,000
Q2 2021

Jun 21, 2023
SELL
$37.41 - $62.25 $489,622 - $814,728
-13,088 Reduced 52.49%
11,848 $630,000
Q1 2021

May 17, 2024
SELL
$35.69 - $52.72 $672,899 - $993,982
-18,854 Reduced 61.41%
11,848 $514,000
Q1 2021

Jun 26, 2023
SELL
$35.69 - $52.72 $467,110 - $689,999
-13,088 Reduced 52.49%
11,848 $514 Million
Q4 2020

May 24, 2024
BUY
$31.71 - $57.97 $214,708 - $392,514
6,771 Added 133.37%
11,848 $615,000
Q4 2020

Jun 22, 2023
SELL
$31.71 - $57.97 $415,020 - $758,711
-13,088 Reduced 52.49%
11,848 $615,000
Q4 2020

Mar 22, 2023
BUY
$31.71 - $57.97 $214,708 - $392,514
6,771 Added 133.37%
11,848 $615,000
Q4 2020

Feb 16, 2021
BUY
$31.71 - $57.97 $214,708 - $392,514
6,771 Added 133.37%
11,848 $615,000
Q3 2020

May 24, 2024
SELL
$27.03 - $47.97 $137,231 - $243,543
-5,077 Reduced 50.0%
5,077 $166 Million
Q3 2020

Jun 26, 2023
SELL
$27.03 - $47.97 $536,788 - $952,636
-19,859 Reduced 79.64%
5,077 $165,000
Q2 2020

May 24, 2024
SELL
$23.2 - $54.8 $476,713 - $1.13 Million
-20,548 Reduced 66.93%
10,154 $488 Million
Q2 2020

Jun 26, 2023
SELL
$23.2 - $54.8 $342,942 - $810,053
-14,782 Reduced 59.28%
10,154 $487,000
Q2 2020

Mar 22, 2023
SELL
$23.2 - $54.8 $460,728 - $1.09 Million
-19,859 Reduced 79.64%
5,077 $243,000
Q2 2020

Aug 14, 2020
BUY
$23.2 - $54.8 $117,786 - $278,219
5,077 New
5,077 $244,000

Others Institutions Holding ZNTL

# of Institutions
140
Shares Held
67.9M
Call Options Held
48.5K
Put Options Held
89.6K
View Full List

About Zentalis Pharmaceuticals, Inc.

ZNTL Quotes by TradingView
  • Ticker ZNTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,983,600
  • Market Cap $108M
  • Description
  • Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...
More about ZNTL
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email